Glaxosmithkline
​Biotechnology pharmaceutical product discovery and development.
Based in DC
🤖
AI Overview
With $1.5M in lobbying spend across 30 quarterly filings, Glaxosmithkline is a significant lobbying presence.
$1.5M
Total Lobbying Spend
30
Quarterly Filings
1
Lobbying Firms Used
6
Individual Lobbyists
Spending by Year
| Year | Lobbying Spend |
|---|---|
| 2018 | $190K |
| 2019 | $250K |
| 2020 | $250K |
| 2021 | $100K |
| 2022 | $200K |
| 2023 | $200K |
| 2024 | $200K |
| 2025 | $100K |
Lobbying Firms
JST STRATEGIES LLC (JOCHUM SHORE & TROSSEVIN PC)
What They Lobby For
- Advocacy for expanded access to vaccines. Advocacy for lupus research within the Department of Defense. Funding for biosecurity and medical countermeasures.
- Part D prescription drug benefit
- Drug pricing issues
- Drug pricing issues and Operation Warp Speed
- drug pricing
- Issues related to drug pricing
- Prescription drug pricing issues
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.